Morgan E Grams1, Yingying Sang2, Josef Coresh3, Shoshana Ballew2, Kunihiro Matsushita2, Miklos Z Molnar4, Zoltan Szabo5, Kamyar Kalantar-Zadeh6, Csaba P Kovesdy7. 1. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. Electronic address: mgrams2@jhmi.edu. 2. Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 3. Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD; Department of Epidemiology, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD; Department of Biostatistics, Johns Hopkins University Bloomberg School of Public Health, Baltimore, MD. 4. Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN. 5. Department of Cardiothoracic Surgery and Cardiothoracic Anesthesia, Linköping University Hospital, Linköping, Sweden; Division of Cardiovascular Medicine, Department of Medical and Health Sciences, Linköping University, Linköping, Sweden. 6. Harold Simmons Center for Chronic Disease Research & Epidemiology, University of California Irvine Medical Center, Irvine, CA; Division of Nephrology & Hypertension, University of California Irvine Medical Center, Orange, CA. 7. Division of Nephrology, University of Tennessee Health Science Center, Memphis, TN; Nephrology Section, Memphis Veterans Affairs Medical Center, Memphis, TN.
Abstract
BACKGROUND: Few trials of acute kidney injury (AKI) prevention after surgery have been conducted, and most observational studies focus on AKI following cardiac surgery. The frequency of, risk factors for, and outcomes after AKI following other types of major surgery have not been well characterized and may present additional opportunities for trials in AKI. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 3.6 million US veterans followed up from 2004 to 2011 for the receipt of major surgery (cardiac; general; ear, nose, and throat; thoracic; vascular; urologic; and orthopedic) and postoperative outcomes. FACTORS: Demographics, health characteristics, and type of surgery. OUTCOMES: Postoperative AKI defined by the KDIGO creatinine criteria, postoperative length of stay, end-stage renal disease, and mortality. RESULTS: Postoperative AKI occurred in 11.8% of the 161,185 major surgery hospitalizations (stage 1, 76%; stage 2, 15%, stage 3 [without dialysis], 7%; and AKI requiring dialysis, 2%). Cardiac surgery had the highest postoperative AKI risk (relative risk [RR], 1.22; 95% CI, 1.17-1.27), followed by general (reference), thoracic (RR, 0.92; 95% CI, 0.87-0.98), orthopedic (RR, 0.70; 95% CI, 0.67-0.73), vascular (RR, 0.68; 95% CI, 0.64-0.71), urologic (RR, 0.65; 95% CI, 0.61-0.69), and ear, nose, and throat (RR, 0.32; 95% CI, 0.28-0.37) surgery. Risk factors for postoperative AKI included older age, African American race, hypertension, diabetes mellitus, and, for estimated glomerular filtration rate < 90mL/min/1.73m(2), lower estimated glomerular filtration rate. Participants with postoperative AKI had longer lengths of stay (15.8 vs 8.6 days) and higher rates of 30-day hospital readmission (21% vs 13%), 1-year end-stage renal disease (0.94% vs 0.05%), and mortality (19% vs 8%), with similar associations by type of surgery and more severe stage of AKI relating to poorer outcomes. LIMITATIONS: Urine output was not available to classify AKI; cohort included mostly men. CONCLUSIONS: AKI was common after major surgery, with similar risk factor and outcome associations across surgery type. These results can inform the design of clinical trials in postoperative AKI to the noncardiac surgery setting.
BACKGROUND: Few trials of acute kidney injury (AKI) prevention after surgery have been conducted, and most observational studies focus on AKI following cardiac surgery. The frequency of, risk factors for, and outcomes after AKI following other types of major surgery have not been well characterized and may present additional opportunities for trials in AKI. STUDY DESIGN: Observational cohort study. SETTING & PARTICIPANTS: 3.6 million US veterans followed up from 2004 to 2011 for the receipt of major surgery (cardiac; general; ear, nose, and throat; thoracic; vascular; urologic; and orthopedic) and postoperative outcomes. FACTORS: Demographics, health characteristics, and type of surgery. OUTCOMES: Postoperative AKI defined by the KDIGO creatinine criteria, postoperative length of stay, end-stage renal disease, and mortality. RESULTS: Postoperative AKI occurred in 11.8% of the 161,185 major surgery hospitalizations (stage 1, 76%; stage 2, 15%, stage 3 [without dialysis], 7%; and AKI requiring dialysis, 2%). Cardiac surgery had the highest postoperative AKI risk (relative risk [RR], 1.22; 95% CI, 1.17-1.27), followed by general (reference), thoracic (RR, 0.92; 95% CI, 0.87-0.98), orthopedic (RR, 0.70; 95% CI, 0.67-0.73), vascular (RR, 0.68; 95% CI, 0.64-0.71), urologic (RR, 0.65; 95% CI, 0.61-0.69), and ear, nose, and throat (RR, 0.32; 95% CI, 0.28-0.37) surgery. Risk factors for postoperative AKI included older age, African American race, hypertension, diabetes mellitus, and, for estimated glomerular filtration rate < 90mL/min/1.73m(2), lower estimated glomerular filtration rate. Participants with postoperative AKI had longer lengths of stay (15.8 vs 8.6 days) and higher rates of 30-day hospital readmission (21% vs 13%), 1-year end-stage renal disease (0.94% vs 0.05%), and mortality (19% vs 8%), with similar associations by type of surgery and more severe stage of AKI relating to poorer outcomes. LIMITATIONS: Urine output was not available to classify AKI; cohort included mostly men. CONCLUSIONS: AKI was common after major surgery, with similar risk factor and outcome associations across surgery type. These results can inform the design of clinical trials in postoperative AKI to the noncardiac surgery setting.
Authors: Tiziana Bove; Giovanni Landoni; Maria Grazia Calabrò; Giacomo Aletti; Giovanni Marino; Elisa Cerchierini; Giuseppe Crescenzi; Alberto Zangrillo Journal: Circulation Date: 2005-06-21 Impact factor: 29.690
Authors: Stanislao Morgera; Rajko Woydt; Hartmut Kern; Martin Schmutzler; Koen DeJonge; Andreas Lun; Wolfgang Rohde; Wolfgang Konertz; Wolfgang J Kox; Hans-Hellmut Neumayer Journal: Crit Care Med Date: 2002-01 Impact factor: 7.598
Authors: Matthew T James; Morgan E Grams; Mark Woodward; C Raina Elley; Jamie A Green; David C Wheeler; Paul de Jong; Ron T Gansevoort; Andrew S Levey; David G Warnock; Mark J Sarnak Journal: Am J Kidney Dis Date: 2015-05-11 Impact factor: 8.860
Authors: Elvira O Gosmanova; Jun L Lu; Elani Streja; William C Cushman; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: Hypertension Date: 2014-08-04 Impact factor: 10.190
Authors: Morgan E Grams; Yingying Sang; Shoshana H Ballew; Ron T Gansevoort; Heejin Kimm; Csaba P Kovesdy; David Naimark; Cecilia Oien; David H Smith; Josef Coresh; Mark J Sarnak; Benedicte Stengel; Marcello Tonelli Journal: Am J Kidney Dis Date: 2015-05-02 Impact factor: 8.860
Authors: Bernhard K Krämer; Jürgen Preuner; Andreas Ebenburger; Michael Kaiser; Ulrich Bergner; Christoph Eilles; Martin C Kammerl; Günter A J Riegger; Dietrich E Birnbaum Journal: Nephrol Dial Transplant Date: 2002-05 Impact factor: 5.992
Authors: Karen E A Burns; Michael W A Chu; Richard J Novick; Stephanie A Fox; Kerri Gallo; Claudio M Martin; Larry W Stitt; A Paul Heidenheim; M Lee Myers; Louise Moist Journal: JAMA Date: 2005-07-20 Impact factor: 56.272
Authors: Sehoon Park; Hyunjeong Cho; Seokwoo Park; Soojin Lee; Kwangsoo Kim; Hyung Jin Yoon; Jiwon Park; Yunhee Choi; Suehyun Lee; Ju Han Kim; Sejoong Kim; Ho Jun Chin; Dong Ki Kim; Kwon Wook Joo; Yon Su Kim; Hajeong Lee Journal: J Am Soc Nephrol Date: 2018-12-18 Impact factor: 10.121
Authors: Devin S Zarkowsky; Caitlin W Hicks; Ian C Bostock; David H Stone; Mohammad Eslami; Philip P Goodney Journal: J Vasc Surg Date: 2016-07-29 Impact factor: 4.268
Authors: Yan Chen; Yingying Sang; Shoshana H Ballew; Adrienne Tin; Alex R Chang; Kunihiro Matsushita; Josef Coresh; Kamyar Kalantar-Zadeh; Miklos Z Molnar; Morgan E Grams Journal: Am J Kidney Dis Date: 2017-03-28 Impact factor: 8.860
Authors: Abduzhappar Gaipov; Miklos Z Molnar; Praveen K Potukuchi; Keiichi Sumida; Zoltan Szabo; Oguz Akbilgic; Elani Streja; Connie M Rhee; Santhosh K G Koshy; Robert B Canada; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: Nephrol Dial Transplant Date: 2019-11-01 Impact factor: 5.992
Authors: Morgan E Grams; Yingying Sang; Josef Coresh; Shoshana H Ballew; Kunihiro Matsushita; Andrew S Levey; Tom H Greene; Miklos Z Molnar; Zoltan Szabo; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: J Am Soc Nephrol Date: 2016-02-08 Impact factor: 10.121
Authors: Elvira O Gosmanova; Margit K Mikkelsen; Miklos Z Molnar; Jun L Lu; Lenar T Yessayan; Kamyar Kalantar-Zadeh; Csaba P Kovesdy Journal: J Am Coll Cardiol Date: 2016-09-27 Impact factor: 24.094